Mechanisms of regulation of rat hepatic metallothionein-I and metallothionein-II levels following administration of zinc. 1988

L D Lehman-McKeeman, and G K Andrews, and C D Klaassen
Department of Pharmacology, University of Kansas Medical Center, Kansas City 66103.

The purpose of this study was to determine the role of transcription, translation, and protein degradation on the accumulation of metallothionein-I (MT-I) and metallothionein-II (MT-II) in rat liver following induction of these proteins by Zn. The time course of MT induction indicated that concentrations of MT-I and MT-II, quantitated by high-performance liquid chromatography, were similar at 6 hr after administration of 1000 mumol Zn/kg (sc), but thereafter the concentration of MT-II was always higher than that of MT-I. By 24 hr after Zn administration, the concentration of MT-II in liver was more than two times that of MT-I. This difference increased with time such that by 96 hr the concentration of MT-II was more than five times that of MT-I. MT-I and MT-II mRNA levels, measured by Northern blot hybridization with mouse cRNA probes, increased coordinately following administration of Zn. MT mRNAs increased to maximum levels 6-9 hr after Zn administration, at which times MT-II mRNA was about two times more abundant than MT-I mRNA. MT mRNA levels remained elevated above control for as long as 36 hr after Zn administration. The relative rates of synthesis for MT-I and MT-II were determined by quantitating incorporation of [35S]cysteine into MTs during a 2-hr period. For both proteins, the maximum relative rates of synthesis were observed 6-9 hr after administration of Zn, in parallel with the increase in mRNA levels. When MT synthesis was at maximal levels, there was approximately two times more [35S]cysteine incorporated into MT-II than MT-I, but at no other times were differences observed. In contrast to MT mRNA levels, MT synthesis returned to control levels by 24 hr after administration of Zn. Half-lives of the isometallothioneins, determined by pulse-labeling experiments, were calculated to be 12.2 +/- 0.8 and 21.9 +/- 3.0 hr for MT-I and MT-II, respectively. Thus, Zn treatment increases transcription of both MT-I and MT-II genes and the synthesis of MT-I and MT-II. However, Zn-induced MT-II is more stable than MT-I. These results suggest that differences in the rate of synthesis and degradation of MT-I and MT-II lead to a greater and more prolonged induction of MT-II following administration of Zn.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008668 Metallothionein A low-molecular-weight (approx. 10 kD) protein occurring in the cytoplasm of kidney cortex and liver. It is rich in cysteinyl residues and contains no aromatic amino acids. Metallothionein shows high affinity for bivalent heavy metals. Isometallothionein,Metallothionein A,Metallothionein B,Metallothionein I,Metallothionein II,Metallothionein IIA
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015032 Zinc A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn.
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

L D Lehman-McKeeman, and G K Andrews, and C D Klaassen
April 1995, Research communications in molecular pathology and pharmacology,
L D Lehman-McKeeman, and G K Andrews, and C D Klaassen
January 1990, Neurochemistry international,
L D Lehman-McKeeman, and G K Andrews, and C D Klaassen
December 2004, Molecules and cells,
L D Lehman-McKeeman, and G K Andrews, and C D Klaassen
June 1980, Toxicology and applied pharmacology,
L D Lehman-McKeeman, and G K Andrews, and C D Klaassen
March 1987, Toxicology and applied pharmacology,
L D Lehman-McKeeman, and G K Andrews, and C D Klaassen
June 1985, Toxicology and applied pharmacology,
L D Lehman-McKeeman, and G K Andrews, and C D Klaassen
April 1987, Toxicology and applied pharmacology,
L D Lehman-McKeeman, and G K Andrews, and C D Klaassen
May 1991, Biochemical and biophysical research communications,
L D Lehman-McKeeman, and G K Andrews, and C D Klaassen
January 1977, Proceedings of the Western Pharmacology Society,
L D Lehman-McKeeman, and G K Andrews, and C D Klaassen
September 1998, Neurochemistry international,
Copied contents to your clipboard!